Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan.

Ziras, N; Potamianou, A; Varthalitis, I; Syrigos, K; Tsousis, S; Boukovinas, I; Tselepatiotis, E; Christofillakis, C; Georgoulias, V

Ziras, N; Potamianou, A; Varthalitis, I; Syrigos, K; Tsousis, S; Boukovinas, I; Tselepatiotis, E; Christofillakis, C; Georgoulias, V.

Affiliation

Ziras N; Department of Medical Oncology, University General Hospital of Heraklion, Greece.

Oncology ; 70(2): 106-14, 2006.

Article in En | MEDLINE | ID: mdl-16645323

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Colorectal Neoplasms/drug therapy; Aged; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Camptothecin/administration & dosage; Camptothecin/analogs & derivatives; Colorectal Neoplasms/pathology; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Disease Progression; Disease-Free Survival; Female; Fluorouracil/administration & dosage; Humans; Irinotecan; Leucovorin/administration & dosage; Male; Middle Aged; Organoplatinum Compounds/administration & dosage; Survival Analysis; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Oncology Year: 2006 Document type: Article Affiliation country: Greece Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links